BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Badenoch JB, Rengasamy ER, Watson C, Jansen K, Chakraborty S, Sundaram RD, Hafeez D, Burchill E, Saini A, Thomas L, Cross B, Hunt CK, Conti I, Ralovska S, Hussain Z, Butler M, Pollak TA, Koychev I, Michael BD, Holling H, Nicholson TR, Rogers JP, Rooney AG. Persistent neuropsychiatric symptoms after COVID-19: a systematic review and meta-analysis. Brain Communications 2022;4:fcab297. [DOI: 10.1093/braincomms/fcab297] [Cited by in Crossref: 20] [Cited by in F6Publishing: 25] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Velichkovsky BB, Razvaliaeva AY, Khlebnikova AA, Manukyan PA, Kasatkin VN. Attention and memory after COVID-19 as measured by neuropsychological tests: Systematic review and meta-analysis. Acta Psychol (Amst) 2023;233:103838. [PMID: 36657196 DOI: 10.1016/j.actpsy.2023.103838] [Reference Citation Analysis]
2 He D, Yuan M, Dang W, Bai L, Yang R, Wang J, Ma Y, Liu B, Liu S, Zhang S, Liao X, Zhang W. Long term neuropsychiatric consequences in COVID-19 survivors: Cognitive impairment and inflammatory underpinnings fifteen months after discharge. Asian J Psychiatr 2022;80:103409. [PMID: 36549172 DOI: 10.1016/j.ajp.2022.103409] [Reference Citation Analysis]
3 Jacot de Alcântara I, Nuber-champier A, Voruz P, Cionca A, Assal F, Péron JA. Cognitive Deficits in the Acute Phase of COVID-19: A Review and Meta-Analysis. JCM 2023;12:762. [DOI: 10.3390/jcm12030762] [Reference Citation Analysis]
4 Muniz Terrera G. Brain sciences and the R words. Brain Commun 2023;5:fcac283. [PMID: 36687393 DOI: 10.1093/braincomms/fcac283] [Reference Citation Analysis]
5 Linnhoff S, Koehler L, Haghikia A, Zaehle T. The therapeutic potential of non-invasive brain stimulation for the treatment of Long-COVID-related cognitive fatigue. Front Immunol 2022;13:935614. [PMID: 36700201 DOI: 10.3389/fimmu.2022.935614] [Reference Citation Analysis]
6 Sakka E, Kalniunas A, Vitkauskaite E, Salman W, Chaudhri S, Pappa S. Psychological Effects and Neuropsychiatric Sequelae in COVID‐19 Patients. Coronavirus Disease 2019 (COVID‐19) 2023. [DOI: 10.1002/9781119789741.ch25] [Reference Citation Analysis]
7 Fessel J. Fluoxetine plus lithium for treatment of mental health impairment in Long Covid. Discov Ment Health 2023;3:1. [PMID: 36618714 DOI: 10.1007/s44192-022-00027-w] [Reference Citation Analysis]
8 Luccarelli J, Kalinich M, McCoy TH Jr, Fricchione G, Smith F, Beach SR. Co-Occurring Catatonia and COVID-19 Diagnoses Among Hospitalized Individuals in 2020: A National Inpatient Sample Analysis. J Acad Consult Liaison Psychiatry 2022:S2667-2960(22)00629-2. [PMID: 36592693 DOI: 10.1016/j.jaclp.2022.12.010] [Reference Citation Analysis]
9 Perrin PB, Ramos-Usuga D, West SJ, Merced K, Klyce DW, Lequerica AH, Olabarrieta-Landa L, Alzueta E, Baker FC, Iacovides S, Cortes M, Arango-Lasprilla JC. Network Analysis of Neurobehavioral Symptom Patterns in an International Sample of Spanish-Speakers with a History of COVID-19 and Controls. Int J Environ Res Public Health 2022;20. [PMID: 36612505 DOI: 10.3390/ijerph20010183] [Reference Citation Analysis]
10 Petrova NN, Pryanikova EV, Pustotin YL, Yakusheva NV, Dorofeikova MV. Post-COVID syndrome in psychiatric practice. RJTAO 2022;14:49-54. [DOI: 10.14412/2074-2711-2022-6-49-54] [Reference Citation Analysis]
11 Drapkina OM, Grigorova OV, Dzhioeva ON, Kostyuk GP, Neznanov NG, Samushiya MA, Chulanov VP. The resolution of the Expert Council on the Diagnosis, Treatment, and Prevention of Symptoms of Depression in Outpatients with New Coronavirus Infection. V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY 2022;56:112-123. [DOI: 10.31363/2313-7053-2022-56-4-112-123] [Reference Citation Analysis]
12 Goldhaber NH, Kohn JN, Ogan WS, Sitapati A, Longhurst CA, Wang A, Lee S, Hong S, Horton LE. Deep Dive into the Long Haul: Analysis of Symptom Clusters and Risk Factors for Post-Acute Sequelae of COVID-19 to Inform Clinical Care. Int J Environ Res Public Health 2022;19. [PMID: 36554723 DOI: 10.3390/ijerph192416841] [Reference Citation Analysis]
13 Mastrorosa I, Duca GD, Pinnetti C, Lorenzini P, Vergori A, Brita AC, Camici M, Mazzotta V, Baldini F, Chinello P, Mencarini P, Giancola ML, Abdeddaim A, Girardi E, Vaia F, Antinori A. What is the impact of post-COVID-19 syndrome on health-related quality of life and associated factors: a cross-sectional analysis.. [DOI: 10.21203/rs.3.rs-2337041/v1] [Reference Citation Analysis]
14 McWhirter L, Smyth H, Hoeritzauer I, Couturier A, Stone J, Carson AJ. What is brain fog? J Neurol Neurosurg Psychiatry 2022:jnnp-2022-329683. [PMID: 36600580 DOI: 10.1136/jnnp-2022-329683] [Reference Citation Analysis]
15 Ford BN, Savitz J. Depression, aging, and immunity: implications for COVID-19 vaccine immunogenicity. Immun Ageing 2022;19:32. [DOI: 10.1186/s12979-022-00288-7] [Reference Citation Analysis]
16 Koczulla AR, Ankermann T, Behrends U, Berlit P, Berner R, Böing S, Brinkmann F, Frank U, Franke C, Glöckl R, Gogoll C, Häuser W, Hohberger B, Huber G, Hummel T, Köllner V, Krause S, Kronsbein J, Maibaum T, Otto-Thöne A, Pecks U, Peters EMJ, Peters S, Pfeifer M, Platz T, Pletz M, Powitz F, Rabe KF, Scheibenbogen C, Schneider D, Stallmach A, Stegbauer M, Tenenbaum T, Töpfner N, von Versen-Höynck F, Wagner HO, Waller C, Widmann CN, Winterholler C, Wirtz H, Zwick R. [German S1 Guideline Long-/Post-COVID]. Pneumologie 2022;76:855-907. [PMID: 36479679 DOI: 10.1055/a-1946-3230] [Reference Citation Analysis]
17 Saes MDO, Vieira YP, Rocha JQS, Silva CN, Soares AO, Neves RG, Gonçalves CDS, Duro SMS. Long COVID and Associated Factors in Individuals From Southern Brazil: a Population-based Study on COVID.. [DOI: 10.21203/rs.3.rs-2099942/v2] [Reference Citation Analysis]
18 Kubota T, Kuroda N, Sone D. Neuropsychiatric aspects of long COVID: A comprehensive review. Psychiatry Clin Neurosci 2022. [PMID: 36385449 DOI: 10.1111/pcn.13508] [Reference Citation Analysis]
19 Chang JG, Ha E, Lee W, Lee SY. Cognitive impairments in patients with subacute coronavirus disease: Initial experiences in a post-coronavirus disease clinic. Front Aging Neurosci 2022;14. [DOI: 10.3389/fnagi.2022.994331] [Reference Citation Analysis]
20 Sampogna G, Di Vincenzo M, Giallonardo V, Perris F, Volpicelli A, Del Vecchio V, Luciano M, Fiorillo A. The Psychiatric Consequences of Long-COVID: A Scoping Review. J Pers Med 2022;12. [PMID: 36579511 DOI: 10.3390/jpm12111767] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Lorkiewicz P, Waszkiewicz N. Is SARS-CoV-2 a Risk Factor of Bipolar Disorder?-A Narrative Review. J Clin Med 2022;11:6060. [PMID: 36294388 DOI: 10.3390/jcm11206060] [Reference Citation Analysis]
22 Saes MDO, Vieira YP, Rocha JQS, Silva CN, Soares AO, Neves RG, Gonçalves CDS, Duro SMS. Long COVID and Associated Factors in Individuals From Southern Brazil: A Population-based Study on COVID.. [DOI: 10.21203/rs.3.rs-2099942/v1] [Reference Citation Analysis]
23 Papagiouvanni I, Kotoulas SC, Vettas C, Sourla E, Pataka A. Sleep During the COVID-19 Pandemic. Curr Psychiatry Rep 2022. [PMID: 36192579 DOI: 10.1007/s11920-022-01371-y] [Reference Citation Analysis]
24 Mantovani A, Morrone MC, Patrono C, Santoro MG, Schiaffino S, Remuzzi G, Bussolati G, Cappuccinelli P, Fitzgerald G, Bacci ML, Melino G, Parisi G, Rappuoli R, Rezza G, Vineis P, On behalf of the Covid-19 Commission of the Accademia Nazionale dei Lincei. Long Covid: where we stand and challenges ahead. Cell Death Differ 2022;29:1891-1900. [DOI: 10.1038/s41418-022-01052-6] [Reference Citation Analysis]
25 Wannasewok K, Suraaroonsamrit B, Jeungsiragulwit D, Udomratn P. Development of Community Mental Health Infrastructure in Thailand: From the Past to the COVID-19 Pandemic. Consortium Psychiatricum 2022;3:98-109. [DOI: 10.17816/cp194] [Reference Citation Analysis]
26 Al-Hadrawi DS, Al-Rubaye HT, Almulla AF, Al-Hakeim HK, Maes M. Lowered oxygen saturation and increased body temperature in acute COVID-19 largely predict chronic fatigue syndrome and affective symptoms due to Long COVID: A precision nomothetic approach. Acta Neuropsychiatr 2022;:1-12. [PMID: 36134517 DOI: 10.1017/neu.2022.21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Orfei MD, Porcari DE, D’arcangelo S, Maggi F, Russignaga D, Ricciardi E. A New Look on Long-COVID Effects: The Functional Brain Fog Syndrome. JCM 2022;11:5529. [DOI: 10.3390/jcm11195529] [Reference Citation Analysis]
28 Vidrio AL, Nicolini H, Zarate CT, Castro TG, Rojop IJ, Magaña JM, López NM, Mendoza ADG. Association between SARS-CoV-2 Infection and Neuropsychiatric Manifestations. COVID 2022;2:1270-1286. [DOI: 10.3390/covid2090094] [Reference Citation Analysis]
29 Golota AS, Vologzhanin DA, Kamilova TA, Sсherbak SG, Makarenko SV. NEUROLOGICAL MANIFESTATIONS IN PATIENTS WITH NEW CORONAVIRUS INFECTION COVID-19. Physical and rehabilitation medicine, medical rehabilitation 2022. [DOI: 10.36425/rehab109952] [Reference Citation Analysis]
30 Badenoch JB, Conti I, Rengasamy ER, Watson CJ, Butler M, Hussain Z, Carter B, Rooney AG, Zandi MS, Lewis G, David AS, Houlihan CF, Easton A, Michael BD, Kuppalli K, Nicholson TR, Pollak TA, Rogers JP. Neurological and psychiatric presentations associated with human monkeypox virus infection: A systematic review and meta-analysis. eClinicalMedicine 2022. [DOI: 10.1016/j.eclinm.2022.101644] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
31 Maes M, Al-Rubaye HT, Almulla AF, Al-Hadrawi DS, Stoyanova K, Kubera M, Al-Hakeim HK. Lowered Quality of Life in Long COVID Is Predicted by Affective Symptoms, Chronic Fatigue Syndrome, Inflammation and Neuroimmunotoxic Pathways. Int J Environ Res Public Health 2022;19:10362. [PMID: 36011997 DOI: 10.3390/ijerph191610362] [Reference Citation Analysis]
32 Rogers JP, Rooney AG. Neuropsychiatric sequelae of COVID-19 after vaccination: A gathering storm? Brain Behav Immun 2022;106:30-1. [PMID: 35933029 DOI: 10.1016/j.bbi.2022.07.166] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
33 Maes M, Al-rubaye HT, Almulla AF, Al-hadrawi DS, Stoyanova K, Kubera M, Al-hakeim HK. Lowered quality of life in Long COVID is strongly predicted by affective symptoms and chronic fatigue syndrome which are associated with inflammatory processes during the acute infectious phase and consequent neuroimmunotoxic pathways.. [DOI: 10.1101/2022.07.25.22277980] [Reference Citation Analysis]
34 Tankisi H, Kamondi A, Gechev A, da Silva AM, Antal A, Destrebecq F, Aarts K, Di Luca M, Cole J. Policy, priorities and practice: 'Being in the room where it happens.' The European Brain Research Area and the Europe, Middle-East and Africa Chapter, International Federation of Clinical Neurophysiology. Clin Neurophysiol 2022;141:75-6. [PMID: 35905630 DOI: 10.1016/j.clinph.2022.07.002] [Reference Citation Analysis]
35 Colizzi M, Peghin M, De Martino M, Bontempo G, Gerussi V, Palese A, Isola M, Tascini C, Balestrieri M. Mental health symptoms one year after acute COVID-19 infection: Prevalence and risk factors. Rev Psiquiatr Salud Ment 2022. [PMID: 35755492 DOI: 10.1016/j.rpsm.2022.05.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
36 Castro VM, Rosand J, Giacino JT, McCoy TH, Perlis RH. Case-control study of neuropsychiatric symptoms in electronic health records following COVID-19 hospitalization in 2 academic health systems. Mol Psychiatry 2022. [PMID: 35705635 DOI: 10.1038/s41380-022-01646-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
37 Cysique LA, Jakabek D, Bracken SG, Allen-davidian Y, Heng B, Chow S, Dehhaghi M, Pires AS, Darley DR, Byrne A, Phetsouphanh C, Kelleher A, Dore GJ, Matthews GV, Guillemin GJ, Brew BJ. Post-acute COVID-19 cognitive impairment and decline uniquely associate with kynurenine pathway activation: a longitudinal observational study.. [DOI: 10.1101/2022.06.07.22276020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Dennis A, Cuthbertson DJ, Wootton D, Crooks M, Gabbay M, Eichert N, Mouchti S, Pansini M, Roca-fernandez A, Thomaides-brears H, Kelly M, Robson M, Hishmeh L, Attree E, Heightman M, Banerjee R, Banerjee A. Multi-organ impairment and Long COVID: a 1-year prospective, longitudinal cohort study.. [DOI: 10.1101/2022.03.18.22272607] [Reference Citation Analysis]
39 Pappa S, Barmparessou Z, Athanasiou N, Sakka E, Eleftheriou K, Patrinos S, Sakkas N, Pappas A, Kalomenidis I, Katsaounou P. Depression, Insomnia and Post-Traumatic Stress Disorder in COVID-19 Survivors: Role of Gender and Impact on Quality of Life. JPM 2022;12:486. [DOI: 10.3390/jpm12030486] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
40 Vasenina E, Gankina O, Levin O. Stress, asthenia and cognitive disorders. Z nevrol psikhiatr im S S Korsakova 2022;122:23. [DOI: 10.17116/jnevro202212205123] [Reference Citation Analysis]
41 Kapfhammer H. Infektionskrankheiten. Depression, Angst, traumatischer Stress und internistische Erkrankungen 2022. [DOI: 10.1007/978-3-662-65873-4_11] [Reference Citation Analysis]
42 Kicherova O, Reikhert L, Akhmetyanov M, Deeva M, Makarova D. Cognitive consequences of COVID-19. Z nevrol psikhiatr im S S Korsakova 2022;122:7. [DOI: 10.17116/jnevro20221221117] [Reference Citation Analysis]